S. Lale Tokgözoğlu, M.D., F.A.C.C., F.E.S.C. was born in 1959 in Ankara, Turkey. She graduated from the Hacettepe University Faculty of Medicine in 1982 on the honor roll. After finishing the Internal Medicine Residency program in the Hacettepe University Faculty of Medicine Department of Internal Medicine on 1988, she completed a fellowship program on Cardiology and Atherosclerosis at the Baylor College of Medicine in Houston, Texas. Dr. Tokgözoğlu returned to the Hacettepe University in 1991 to become Associate Professor of Cardiology, and later Professor of Cardiology in 1998.
Prof. Tokgözoğlu has served on the Executive Committee of the European Society of Atherosclerosis as member between 2003 and 2005, as Secretary between 2005-2009, as Vice President of the European Atherosclerosis Society between 2009-2013 and as President since January 2017. She was the President of the 77th European Atherosclerosis Society meeting in Istanbul. She also served as the President of the ‘Atherosclerosis and Vascular Biology Working Group of the European Society of Cardiology’ between 2008 and 2010. She has served for 2 years on board of the European Society of Cardiology Fellowship and Training Committee and for 2 years on the board of the Education Committee. She has also served first as Member-at-Large (Europe) of the Executive Committee of the International Society of Atherosclerosis, then as President of the European Federation of the International Atherosclerosis Society followed by the post of Secretary of the International Society of Atherosclerosis.
Prof. Tokgözoğlu has served on the Board of the Prevention Association of the European Society of Cardiology chairing their Education Committee. She has been a member of the Young Investigator Award Committees of the International Atherosclerosis Society in Stockholm 2000, European Atherosclerosis Society in Prague in 2005 and has served in the Scientific Program Committe of the European Society of Cardiology in 2009, 2010, 2015, 2016, 2017 and 2018.
Prof. Tokgözoğlu has been elected to the ‘Science Academy in Turkey’ in 2014.
Prof. Tokgözoğlu has served as the Secretary of the Lipid Working Group of the Turkish Society of Cardiology between 1994 and 1996, as President of the Lipid Working Group of the Turkish Society of Cardiology between 1998 and 2000. She has been on the Executive Committee of the Turkish Society of Cardiology for 6 years between 2000 and 2006 and as Vice President between 2008 and 2010 and the President of the Turkish Society of Cardiology between 2014-2016. She was the first female President of this society in its history of 52 years. She has chaired the ‘Research Committee of the Turkish Society of Cardiology’ for 4 years. She is the founding member of the Atherosclerosis Research and Education Society in Turkey. Prof Tokgözoğlu is one of the authors of the ‘National Heart Health Policy’ for Turkey. She has been on the Guideline Committee for the Prevention of Coronary Heart Disease in Turkey in 1995 and in 2002 when the Guidelines were revised.She has also been an author on the EAS/ESC dyslipidemia guideines in 2011. She also received the Paul Dudley White International Science Team Award in 2017.
Prof. Tokgözoğlu is currently a Fellow of the American College of Cardiology and European Society of Cardiology. She is also member of many societies of her specialty. She has won the “Prof. Dr. Şeref Zileli “Resident of the Year” Award in 1987; the Sandoz Scientific Award in 1989 and the “Young Investigator Award” of the Turkish Society of Cardiology in 1994 and second runner up in the Pfizer Cardiology Scientific Award in 1999. She also received the Paul Dudley White International Science Team Award in 2017.
Monday 30 November 00:00
Dyslipidaemia guidelines: What is new?
Dyslipidaemia guidelines: What is new?
Sunday 26 May 16:00
Physician-patient relationship: Challenges and opportunities
How can we improve outcomes in our patients with CAD?
Monday 27 May 08:05
Roundtable discussion and Q&A - making sense of the latest data and what it means for high risk patients
RECENT STUDY UPDATES: MANAGING CHOLESTEROL IN HIGH RISK PATIENTS